Q&A on Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
June 19 @ 2:30 pm, EDT - 3:30 pm, EDT
SEND US YOUR QUESTIONS FOR THE EXPERTS HERE
(During the podcast, you can interact with the moderator through our TMA Facebook page, or using the chat function in GoToWebinar)
Benjamin Greenberg, MD, MHS
University of Texas Southwestern Medical Center
Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Masters Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He completed his residency in neurology at The Johns Hopkins Hospital and then joined the faculty within the division of neuroimmunology. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis and infections of the nervous system. He currently serves as the Director of the Neurosciences Clinical Research Center and is a Cain Denius Foundation Scholar.
Listen to previous Ask the Expert podcasts here